Positive correlation between plasma PCSK9 and tissue factors levels in patients with angiographically diagnosed coronary artery disease and diabetes mellitus

被引:0
|
作者
Mei WANG [1 ]
YanFang LI [1 ,2 ]
YanGing GUO [1 ]
MengMeng CHEN [1 ]
ZhiLi JIANG [1 ]
JunYing SONG [1 ]
机构
[1] Emergency & Critical Care Center,Beijing Anzhen Hospital,Capital Medical University
[2] Beijing Institute of Heart Lung and Blood Vessel
关键词
D O I
暂无
中图分类号
R543.3 [冠状动、静脉疾病]; R587.1 [糖尿病];
学科分类号
摘要
Background Pro-protein convertase subtilisin/kexin type 9(PCSK9) is a secreted protein that influences plasma levels of low-density lipoprotein cholesterol(LDL-C).Both oxidized LDL and tissue factor(TF) contributed to the development of prothrombotic state.The present study aims to explore the relationship between plasma level of PCSK9 and that of TF in patient with coronary artery disease(CAD).Methods From July 2013 to March 2014,we enrolled 197 consecutive patients who underwent coronary angiography because of suspected CAD at Beijing Anzhen Hospital in this study.All patients had no history of using lipid-lowering medication.Of these 197 patients(131male and 66 female,mean age 56.9 ± 11.8 years),81 had angiographicaUy diagnosed CAD.Clinical data were collected.Plasma PCSK9 and TF were measured using enzyme-linked immunosorbent assay(ELISA).Levels of plasma PCSK9 and TF were compared and their correlation analyzed among different patient groups.Results Both plasma levels of PCSK9(279.8 ± 60.4μg/L vs.216.5 ± 45.3μg/L,P < 0.01)and TF(156.4 ± 26.6μg/mL vs.112.1 ± 38.3 ug/L,P < 0.01) were significantly higher in patients with CAD,as compared with those without CAD.Correlation analysis showed plasma level of PCSK9 was significantly correlated with that of TF in both patients with and without CAD.However,multivariate regression analysis after adjustment for age,gender,smoking,alcohol,hypertension and hyperlipidemia showed that only in CAD patients with type 2 diabetes mellitus,there was significant positive correlation between plasma levels of PCSK9 and TF(P = 0.353,P < 0.01).Conclusions The plasma level of PCSK9 is independently and positively associated with that of TF in CAD patients with diabetes mellitus,but not in those without diabetes mellitus.Further study is needed to investigate the underlying mechanism.
引用
收藏
页码:312 / 315
页数:4
相关论文
共 50 条
  • [21] Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease
    Li, Sha
    Guo, Yuan-Lin
    Xu, Rui-Xia
    Zhang, Yan
    Zhu, Cheng-Gang
    Sun, Jing
    Qing, Ping
    Wu, Na-Qiong
    Jiang, Li-Xin
    Li, Jian-Jun
    ATHEROSCLEROSIS, 2014, 234 (02) : 441 - 445
  • [22] Plasma PCSK9 Levels are associated with the severity of coronary stenosis in patients with atherosclerosis
    Li, Sha
    Guo, Yuanlin
    Xu, Ruixia
    Zhang, Yan
    Zhu, Chenggang
    Sun, Jing
    Qing, Ping
    Wu, Naqiong
    Li, Jianjun
    CARDIOLOGY, 2014, 129 : 14 - 15
  • [23] Plasma PCSK9 levels are associated with the severity of coronary stenosis in patients with atherosclerosis
    Li, Sha
    Guo, Yuan-Lin
    Xu, Rui-Xia
    Zhang, Yan
    Zhu, Cheng-Gang
    Sun, Jing
    Qing, Ping
    Wu, Na-Qiong
    Li, Jian-Jun
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 174 (03) : 863 - 864
  • [24] Plasma PCSK9 is associated with the severity of coronary artery lesions in patients with acute coronary syndrome
    Cariou, B.
    Guerin, P.
    Pichelin, M.
    Arnaud, L.
    Le May, C.
    Prieur, X.
    Guyomarch, B.
    Probst, V.
    DIABETOLOGIA, 2016, 59 : S530 - S530
  • [25] PCSK9 GENETIC VARIANTS IN PATIENTS WITH CORONARY ARTERY DISEASE - A PILOT STUDY
    Ashavaid, T. F.
    Bane, A.
    Ponde, C. K.
    Rajani, R. M.
    Pillai, S.
    ATHEROSCLEROSIS, 2018, 275 : E224 - E225
  • [26] Proprotein convertase subtilisin/kexin type 9 (PCSK9) plasma levels are associated with the metabolic syndrome in patients with stable coronary artery disease
    Caselli, C.
    Ragusa, R.
    Del Turco, S.
    Basta, G.
    Saraste, A.
    Knuuti, J.
    De Caterina, R.
    Neglia, D.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3802 - 3802
  • [27] Effect of PCSK9 inhibition on platelet reactivity in coronary artery disease patients
    Galli, Lukas
    Ondracek, Anna
    Seidl, Veronika
    Hofbauer, Thomas
    Zedan, Yasmin
    Schrutka, Lore
    Krychtiuk, Konstantin
    Lang, Irene M.
    Speidl, Walter
    Distelmaier, Klaus
    WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : 372 - 373
  • [28] Angiographically diagnosed coronary artery disease among asymptomatic subjects with type 2 diabetes mellitus
    Johansen, Odd E.
    Birkeland, Kare I.
    Endresen, Knut
    Smith, Camilla
    Ueland, Thor
    Orvik, Elsa
    Aukrust, Pal
    Gullestad, Lars
    DIABETES, 2006, 55 : A492 - A492
  • [29] Low PCSK9 plasma level is an independent predictor of coronary atherosclerotic burden in patients with stable coronary artery disease
    Caselli, C.
    Ragusa, R.
    Del Turco, S.
    De Graaf, M.
    Basta, G.
    Scholte, A.
    De Caterina, R.
    Neglia, D.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3780 - 3780
  • [30] Plasma PCSK9 levels and atherosclerosis burden in the coronary arteries of patients undergoing coronary angiography
    Panahi, Y.
    Ghahrodi, M. S.
    Jamshir, M. S.
    Safarpour, M. A.
    Pirro, M.
    Bianconi, V.
    Farahani, M. M.
    Banach, M.
    Sahebkar, A.
    EUROPEAN HEART JOURNAL, 2019, 40 : 472 - 472